<DOC>
	<DOCNO>NCT00697736</DOCNO>
	<brief_summary>Systemic sclerodermia connectivity characterize multiple visceral impairment , particular pulmonary , lead development Pulmonary Arterial Hypertension ( PAHT ) . In one hand , PAHT evolutionary turn symptomatology prognosis , hand , track analysis effect right ventricular function difficult conventional technique . So , analysis right ventricular function appear capital , : - recognize like essential determinant symptom effort capacity , - prevalence , physiopathology prognostic value remain unknown pathology , - interest start treatment remain specify . The aim trial identify population 150 patient present systemic scleroderma without PAHT : - incidence right ventricular dysfonction , evaluate analysis myocardic regional function myocardial tissular Doppler mode , - physiopathology damage correlation test respiratory function invasive hemodynamic data rest exercise . - prognosis value abnormality right ventricular function follow-up patient 5 year period . This trial allow define place new right ventricular function marker evaluation functional consequence , forecast perhaps care systemic sclerodermic patient .</brief_summary>
	<brief_title>Cardiac Repercussion Systemic Sclerodermias</brief_title>
	<detailed_description />
	<mesh_term>Scleroderma , Systemic</mesh_term>
	<mesh_term>Scleroderma , Diffuse</mesh_term>
	<criteria>Age 18 year 75 year Having maximum speed IT &lt; 2.8 m/sec . Having read understood information note sign informed consent form . And : Either carry systemic sclerodermia satisfy criterion American College Rheumatology ( presence major criterion two minor criterias require systemic diagnosis sclerodermia ) : Major criterion : proximal sclerodermia define bilateral cutaneous sclerosis extend beyond metacarpophalangeal metatarsophalangeal joint . Minor criterion : pulpar sclerodactylia , pulpar canker scar , pulmonary fibrosis thoracic radiography . Or present CREST syndrome , least 4 5 follow criterias : subcutaneous calcinosis , syndrome Raynaud , attack oesophagienne , sclerodactylia , telangiectasis . Over 75 year Having maximum speed TI &gt; 2.8 m/sec . Patient affect connectivitis sclerodermia : mixed connectivity , disseminate erythematous lupus , inflammatory idiopathic myopathy , rheumato√Ød polyarthritis . Patient carry sclerodermia complicate : renal failure ( clearance &gt; 30 ml Cockraft ) recent heart failure ( &lt; 2 month ) cardiac valvular attack , dilate , hypertrophic restrictive cardiomyopathy , constrictive pericarditis , chronic pulmonary heart antecedent myocarditis Coronaropathy objectify stenosis simple coronary irregularity coronarography antecedent myocardial infarction Chronic respiratory handicap another origin sclerodermia Unsigned informed consent form Patient mental psychiatric disorder , unable unwilling comply protocol requirement . Patient treat intraveinous derive prostacyclin within 1 month inclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Systemic Scleroderma</keyword>
	<keyword>Echocardiography</keyword>
</DOC>